ASCO® 2026 Highlights: Presenter Vignette – Pavlos Msaouel

Dr. Pavlos Msaouel

Pavlos Msaouel

MD, PhD

MD Anderson Cancer Center

4520

Prospective clinical activity and preclinical basis of panitumumab-based EGFR blockade in SMARCB1-deficient renal medullary carcinoma (RMC): A collaborative multi-institutional study.